Trial Profile
The phase III study of JHL 1188, for the treatment of breast cancer
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 29 Mar 2022
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Breast cancer
- Focus Registrational; Therapeutic Use
- Sponsors Eden Biologics
- 24 Aug 2018 New trial record